|
DE2843963A1
(de)
*
|
1978-10-09 |
1980-04-24 |
Merck Patent Gmbh |
Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin
|
|
US4374121A
(en)
*
|
1979-09-12 |
1983-02-15 |
Seton Company |
Macromolecular biologically active collagen articles
|
|
JPS5767521A
(en)
*
|
1980-09-25 |
1982-04-24 |
Yamanouchi Pharmaceut Co Ltd |
Agent for improving circulation blood vessel
|
|
US4304765A
(en)
*
|
1980-10-14 |
1981-12-08 |
Alza Corporation |
Ocular insert housing steroid in two different therapeutic forms
|
|
US4432964A
(en)
*
|
1981-08-24 |
1984-02-21 |
Alza Corporation |
Topical composition containing steroid in two forms released independently from polymeric carrier
|
|
FR2524312B1
(fr)
*
|
1982-04-01 |
1985-10-04 |
Tech Cuir Centre |
Nouvelles formes de micro-encapsulation de substances medicamenteuses par des couches homogenes de collagene natif
|
|
US4505855A
(en)
*
|
1982-09-30 |
1985-03-19 |
Massachusetts General Hospital |
Transparent non-fibrilized collagen material by ultracentrifugation
|
|
US4478818A
(en)
*
|
1982-12-27 |
1984-10-23 |
Alza Corporation |
Ocular preparation housing steroid in two different therapeutic forms
|
|
GB8306353D0
(en)
*
|
1983-03-08 |
1983-04-13 |
Stuart J F B |
Monitoring of drug levels
|
|
JPS6025920A
(ja)
*
|
1983-07-22 |
1985-02-08 |
Japan Atom Energy Res Inst |
薬物含有徐放性複合体及びその調製方法
|
|
JPS6028936A
(ja)
*
|
1983-07-27 |
1985-02-14 |
Koken:Kk |
アテロコラ−ゲン水溶液およびその製造方法
|
|
JPS6084213A
(ja)
*
|
1983-10-14 |
1985-05-13 |
Sumitomo Chem Co Ltd |
徐放性消炎鎮痛製剤
|
|
JPS6089418A
(ja)
*
|
1983-10-20 |
1985-05-20 |
Sumitomo Chem Co Ltd |
徐放性制癌剤
|
|
US4563184A
(en)
*
|
1983-10-17 |
1986-01-07 |
Bernard Korol |
Synthetic resin wound dressing and method of treatment using same
|
|
FR2559780B1
(fr)
*
|
1984-02-21 |
1990-05-04 |
Tech Cuir Centre |
Systemes biocompatibles implantables a base de collagene permettant la conservation et/ou la culture cellulaires et/ou la liberation controlee de principes actifs
|
|
US4748152A
(en)
*
|
1985-01-22 |
1988-05-31 |
Opticol Corp. |
Succinylated atelocollagen solution for use in viscosurgery and as a vitreous substitute
|
|
US4713446A
(en)
*
|
1985-09-06 |
1987-12-15 |
Minnesota Mining And Manufacturing Company |
Viscoelastic collagen solution for ophthalmic use and method of preparation
|
|
US4851513A
(en)
*
|
1985-09-06 |
1989-07-25 |
Minnesota Mining And Manufacturing Company |
Viscoelastic collagen solution for opthalmic use and method of preparation
|
|
US4883864A
(en)
*
|
1985-09-06 |
1989-11-28 |
Minnesota Mining And Manufacturing Company |
Modified collagen compound and method of preparation
|
|
ATE87469T1
(de)
*
|
1985-12-27 |
1993-04-15 |
Sumitomo Pharma |
Verfahren zur herstellung einer formulierung mit verzoegerter freisetzung.
|
|
FR2601371B1
(fr)
*
|
1986-07-11 |
1989-05-12 |
Merieux Inst |
Procede de traitement du collagene en vue, notamment, d'en faciliter la reticulation et collagene obtenu par application dudit procede
|
|
US5128134A
(en)
*
|
1986-09-17 |
1992-07-07 |
Fyodorov Svyatoslav N |
Ophthalmological collagen coverings
|
|
US5147647A
(en)
*
|
1986-10-02 |
1992-09-15 |
Sohrab Darougar |
Ocular insert for the fornix
|
|
US5989579A
(en)
*
|
1986-10-02 |
1999-11-23 |
Escalon Medical Corp. |
Ocular insert with anchoring protrusions
|
|
US5322691A
(en)
*
|
1986-10-02 |
1994-06-21 |
Sohrab Darougar |
Ocular insert with anchoring protrusions
|
|
US5094855A
(en)
*
|
1986-10-13 |
1992-03-10 |
Moskovsky Nauchno-Teknichesky Compleks "Mikrochirurgija Glaza" |
Opthalmological collagen coverings
|
|
EP0326151B1
(en)
*
|
1988-01-29 |
1993-06-16 |
Sumitomo Pharmaceuticals Company, Limited |
Improved controlled release formulation
|
|
US4969912A
(en)
*
|
1988-02-18 |
1990-11-13 |
Kelman Charles D |
Human collagen processing and autoimplant use
|
|
AU632273B2
(en)
*
|
1988-03-09 |
1992-12-24 |
Terumo Kabushiki Kaisha |
Medical material permitting cells to enter thereinto and artificial skin
|
|
US4882150A
(en)
*
|
1988-06-03 |
1989-11-21 |
Kaufman Herbert E |
Drug delivery system
|
|
US4923700A
(en)
*
|
1988-06-03 |
1990-05-08 |
Kaufman Herbert E |
Artificial tear suspension
|
|
US4865846A
(en)
*
|
1988-06-03 |
1989-09-12 |
Kaufman Herbert E |
Drug delivery system
|
|
US4923699A
(en)
*
|
1988-06-03 |
1990-05-08 |
Kaufman Herbert E |
Eye treatment suspension
|
|
US5565519A
(en)
*
|
1988-11-21 |
1996-10-15 |
Collagen Corporation |
Clear, chemically modified collagen-synthetic polymer conjugates for ophthalmic applications
|
|
US5475052A
(en)
*
|
1988-11-21 |
1995-12-12 |
Collagen Corporation |
Collagen-synthetic polymer matrices prepared using a multiple step reaction
|
|
US5936035A
(en)
*
|
1988-11-21 |
1999-08-10 |
Cohesion Technologies, Inc. |
Biocompatible adhesive compositions
|
|
US5800541A
(en)
*
|
1988-11-21 |
1998-09-01 |
Collagen Corporation |
Collagen-synthetic polymer matrices prepared using a multiple step reaction
|
|
US4946450A
(en)
*
|
1989-04-18 |
1990-08-07 |
Biosource Genetics Corporation |
Glucan/collagen therapeutic eye shields
|
|
US4978352A
(en)
*
|
1989-06-07 |
1990-12-18 |
Fedorov Svjatoslav N |
Process for producing collagen-based cross-linked biopolymer, an implant from said biopolymer, method for producing said implant, and method for hermetization of corneal or scleral wounds involved in eye injuries, using said implant
|
|
US5138030A
(en)
*
|
1989-10-10 |
1992-08-11 |
Pachence James M |
Process for extracting type I collagen form an avian source, and applications therefor
|
|
JPH03121203U
(enExample)
*
|
1990-03-27 |
1991-12-12 |
|
|
|
US5103840A
(en)
*
|
1990-05-07 |
1992-04-14 |
Kavoussi Harold P |
Viscoelastic collagen gel for ophthalmic surgery
|
|
US5322648A
(en)
*
|
1991-08-26 |
1994-06-21 |
Vitaphore Corporation |
Process for forming shaped collagen devices
|
|
US5259998A
(en)
*
|
1991-10-04 |
1993-11-09 |
Chiron Ophthalmics, Inc. |
Method for casting dissolvable ophthalmic shields in a mold
|
|
CA2140053C
(en)
*
|
1994-02-09 |
2000-04-04 |
Joel S. Rosenblatt |
Collagen-based injectable drug delivery system and its use
|
|
US5466233A
(en)
*
|
1994-04-25 |
1995-11-14 |
Escalon Ophthalmics, Inc. |
Tack for intraocular drug delivery and method for inserting and removing same
|
|
DE4414755C2
(de)
*
|
1994-04-27 |
2000-11-16 |
Lohmann Therapie Syst Lts |
Kollagenzubereitung zur gesteuerten Abgabe von Wirkstoffen, Verfahren und Verwendung
|
|
US5928667A
(en)
*
|
1994-06-24 |
1999-07-27 |
University Of Maryland |
Drug delivery device and method for employing the same
|
|
EP0713707A1
(en)
|
1994-11-23 |
1996-05-29 |
Collagen Corporation |
In situ crosslinkable, injectable collagen composition for tissue augmention
|
|
US5518732A
(en)
*
|
1995-02-14 |
1996-05-21 |
Chiron Vision, Inc. |
Bio-erodible ophthalmic shield
|
|
EP0815212A1
(en)
*
|
1995-03-03 |
1998-01-07 |
Metabolex, Inc. |
Novel encapsulation process by a gelling polymer
|
|
US5916790A
(en)
*
|
1995-03-03 |
1999-06-29 |
Metabolex, Inc. |
Encapsulation compositions, and methods
|
|
DE19508029C2
(de)
*
|
1995-03-07 |
1997-10-09 |
Richard Prof Dr Sueverkruep |
Darreichungsform zur äußerlichen Applikation von ophthalmischen Arzneistoffen und Verfahren zur Herstellung derselben
|
|
US6962979B1
(en)
*
|
1995-03-14 |
2005-11-08 |
Cohesion Technologies, Inc. |
Crosslinkable biomaterial compositions containing hydrophobic and hydrophilic crosslinking agents
|
|
US5788959A
(en)
*
|
1995-04-24 |
1998-08-04 |
University Of Maryland, Baltimore County |
Drug delivery device and method for employing the same
|
|
US5677284A
(en)
*
|
1995-06-06 |
1997-10-14 |
Regen Biologics, Inc. |
Charged collagen particle-based delivery matrix
|
|
PT2111876E
(pt)
*
|
1995-12-18 |
2011-12-23 |
Angiodevice Internat Gmbh |
Composições de polímero reticulado e seus métodos de utilização
|
|
US6458889B1
(en)
|
1995-12-18 |
2002-10-01 |
Cohesion Technologies, Inc. |
Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
|
|
US6495127B1
(en)
|
1999-08-27 |
2002-12-17 |
Cohesion Technologies, Inc. |
Compositions and systems for forming high strength medical sealants, and associated methods of preparation and use
|
|
US7883693B2
(en)
|
1995-12-18 |
2011-02-08 |
Angiodevice International Gmbh |
Compositions and systems for forming crosslinked biomaterials and methods of preparation of use
|
|
US6833408B2
(en)
|
1995-12-18 |
2004-12-21 |
Cohesion Technologies, Inc. |
Methods for tissue repair using adhesive materials
|
|
KR19990071782A
(ko)
*
|
1996-01-05 |
1999-09-27 |
왈리스 조 앤 |
유형ⅱ 콜라겐의 제조방법
|
|
US6299895B1
(en)
|
1997-03-24 |
2001-10-09 |
Neurotech S.A. |
Device and method for treating ophthalmic diseases
|
|
US8603511B2
(en)
|
1996-08-27 |
2013-12-10 |
Baxter International, Inc. |
Fragmented polymeric compositions and methods for their use
|
|
US6066325A
(en)
|
1996-08-27 |
2000-05-23 |
Fusion Medical Technologies, Inc. |
Fragmented polymeric compositions and methods for their use
|
|
US7435425B2
(en)
|
2001-07-17 |
2008-10-14 |
Baxter International, Inc. |
Dry hemostatic compositions and methods for their preparation
|
|
US8303981B2
(en)
|
1996-08-27 |
2012-11-06 |
Baxter International Inc. |
Fragmented polymeric compositions and methods for their use
|
|
AU6019898A
(en)
|
1997-01-09 |
1998-08-03 |
Cohesion Technologies, Inc. |
Devices for tissue repair and methods for preparation and use thereof
|
|
JPH1156897A
(ja)
*
|
1997-08-18 |
1999-03-02 |
Koken Co Ltd |
コラーゲン眼科手術補助剤
|
|
US6197934B1
(en)
*
|
1998-05-22 |
2001-03-06 |
Collagenesis, Inc. |
Compound delivery using rapidly dissolving collagen film
|
|
WO2001013119A1
(en)
*
|
1999-08-17 |
2001-02-22 |
Luminex Corporation |
Encapsulation of fluorescent particles
|
|
US20050004158A1
(en)
|
2003-06-19 |
2005-01-06 |
Vascular Therapies Llc |
Medical implants and methods for regulating the tissue response to vascular closure devices
|
|
AP2003002828A0
(en)
|
2001-01-16 |
2003-09-30 |
Vascular Therapies Llc |
Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts.
|
|
ATE506929T1
(de)
|
2001-06-12 |
2011-05-15 |
Univ Johns Hopkins Med |
Reservoirvorrichtung für die intraokulare arzneimittelabgabe
|
|
US20030181371A1
(en)
*
|
2001-12-28 |
2003-09-25 |
Angiotech Pharmaceuticals, Inc. |
Compositions and methods of using collajolie
|
|
EP1555957A4
(en)
*
|
2002-10-04 |
2010-11-24 |
Nanomatrix Inc |
SEALANT FOR SKIN AND OTHER FABRICS
|
|
US20050013845A1
(en)
*
|
2002-11-12 |
2005-01-20 |
Warren Stephen L. |
Adhesive bioerodible ocular drug delivery system
|
|
US20040219214A1
(en)
*
|
2002-12-30 |
2004-11-04 |
Angiotech International Ag |
Tissue reactive compounds and compositions and uses thereof
|
|
EP1594459B1
(en)
*
|
2002-12-30 |
2010-02-17 |
Angiotech International Ag |
Drug delivery from rapid gelling polymer composition
|
|
US8834864B2
(en)
*
|
2003-06-05 |
2014-09-16 |
Baxter International Inc. |
Methods for repairing and regenerating human dura mater
|
|
US7927626B2
(en)
*
|
2003-08-07 |
2011-04-19 |
Ethicon, Inc. |
Process of making flowable hemostatic compositions and devices containing such compositions
|
|
CA2536454C
(en)
|
2003-08-26 |
2013-03-26 |
Vista Scientific |
Ocular drug delivery device
|
|
BRPI0510477B1
(pt)
|
2004-04-28 |
2023-01-17 |
Angiotech Biomaterials Corporation |
Método para formar um gel e dispositivo para uso em aplicações médicas
|
|
WO2006034128A2
(en)
|
2004-09-17 |
2006-03-30 |
Angiotech Biomaterials Corporation |
Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use
|
|
KR20070083941A
(ko)
*
|
2004-10-04 |
2007-08-24 |
큐엘티 유에스에이, 인코포레이티드 |
중합체 전달 조성을 갖는 눈 전달
|
|
US8313763B2
(en)
*
|
2004-10-04 |
2012-11-20 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of rapamycin compounds
|
|
US20060205789A1
(en)
*
|
2005-03-04 |
2006-09-14 |
Neurosystec Corporation |
Gacyclidine formulations
|
|
WO2006113845A1
(en)
*
|
2005-04-19 |
2006-10-26 |
Therabit, Inc. |
Implantable tissue-reactive biomaterial compositions and systems, and methods of use thereof
|
|
US20060247776A1
(en)
*
|
2005-05-02 |
2006-11-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Systems and methods for augmenting intervertebral discs
|
|
US20070005140A1
(en)
*
|
2005-06-29 |
2007-01-04 |
Kim Daniel H |
Fabrication and use of biocompatible materials for treating and repairing herniated spinal discs
|
|
US20070233252A1
(en)
*
|
2006-02-23 |
2007-10-04 |
Kim Daniel H |
Devices, systems and methods for treating intervertebral discs
|
|
NZ595623A
(en)
|
2006-03-31 |
2013-01-25 |
Mati Therapeutics Inc |
A drug insert surrounded by a sheath to expose a polymer containing a drug to surrounding tissues or an eye
|
|
KR20090017654A
(ko)
*
|
2006-05-31 |
2009-02-18 |
백스터 인터내셔널 인코포레이티드 |
척수 수술에서 세포 내성장을 통제하고 조직 재생을 조절하는 방법
|
|
US7803148B2
(en)
*
|
2006-06-09 |
2010-09-28 |
Neurosystec Corporation |
Flow-induced delivery from a drug mass
|
|
TWI436793B
(zh)
|
2006-08-02 |
2014-05-11 |
巴克斯特國際公司 |
快速作用之乾密封膠及其使用和製造方法
|
|
WO2008035376A2
(en)
*
|
2006-09-19 |
2008-03-27 |
Council Of Scientific & Industrial Research |
A novel bio-erodible insert for ophthalmic applications and a process for the preparation thereof
|
|
US8685107B2
(en)
|
2007-07-03 |
2014-04-01 |
Histogenics Corporation |
Double-structured tissue implant and a method for preparation and use thereof
|
|
US20090054984A1
(en)
|
2007-08-20 |
2009-02-26 |
Histogenics Corporation |
Method For Use Of A Double-Structured Tissue Implant For Treatment Of Tissue Defects
|
|
AR069109A1
(es)
|
2007-10-30 |
2009-12-30 |
Baxter Int |
Uso de una biomatriz de colageno biofuncional regenerativa para tratar defectos viscerales o parietales
|
|
AU2009208729A1
(en)
*
|
2008-01-31 |
2009-08-06 |
Sofradim Production |
Preparation of terminally-sterilized collagen that is soluble at neutral pH
|
|
RU2545810C2
(ru)
|
2008-02-29 |
2015-04-10 |
Ферросан Медикал Дивайсиз А/С |
Устройство для ускорения остановки кровотечения и/или заживления ран
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
PL2391419T3
(pl)
|
2009-01-29 |
2019-12-31 |
Forsight Vision4, Inc. |
Dostarczanie leku do tylnego odcinka
|
|
US20100226962A1
(en)
*
|
2009-03-03 |
2010-09-09 |
Rodstrom Theron R |
Peri-corneal drug delivery device
|
|
US9039783B2
(en)
*
|
2009-05-18 |
2015-05-26 |
Baxter International, Inc. |
Method for the improvement of mesh implant biocompatibility
|
|
ES2532428T3
(es)
*
|
2009-06-16 |
2015-03-26 |
Baxter International Inc |
Esponja hemostática
|
|
PT2464232E
(pt)
|
2009-08-10 |
2016-02-01 |
Samumed Llc |
Inibidores de indazol da via de sinalização wnt e usos terapêuticos dos mesmos
|
|
DK2485779T3
(en)
*
|
2009-10-07 |
2018-05-07 |
Kerecis Ehf |
A FRAME MATERIAL FOR SCREENING AND / OR OTHER TISSUE HEALING APPLICATIONS
|
|
EP2486128A4
(en)
*
|
2009-10-08 |
2013-10-09 |
Neurotech Usa Inc |
USE OF THE PEDF IN AN ENCAPSULATED CELL DELIVERY SYSTEM
|
|
MX2012007056A
(es)
|
2009-12-16 |
2012-09-28 |
Baxter Healthcare Sa |
Esponja hemostatica.
|
|
JP5822844B2
(ja)
|
2009-12-21 |
2015-11-24 |
サミュメッド リミテッド ライアビリティ カンパニー |
１Ｈ−ピラゾロ［３，４−ｂ］ピリジンおよびその治療的使用
|
|
WO2011094170A1
(en)
*
|
2010-01-27 |
2011-08-04 |
Alcon Research, Ltd. |
Pulsatile peri-corneal drug delivery device
|
|
US10166142B2
(en)
|
2010-01-29 |
2019-01-01 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
|
SA111320355B1
(ar)
|
2010-04-07 |
2015-01-08 |
Baxter Heathcare S A |
إسفنجة لايقاف النزف
|
|
AU2011260274B2
(en)
|
2010-06-01 |
2015-07-02 |
Baxter Healthcare S.A. |
Process for making dry and stable hemostatic compositions
|
|
AU2011260260B2
(en)
|
2010-06-01 |
2015-09-03 |
Baxter Healthcare S.A. |
Process for making dry and stable hemostatic compositions
|
|
MX344402B
(es)
|
2010-06-01 |
2016-12-14 |
Baxter Int Inc * |
Proceso para elaborar composiciones hemostaticas secas y estables.
|
|
SG187664A1
(en)
*
|
2010-08-02 |
2013-03-28 |
Euclid Systems Corp |
Collagen-based implants for sustained delivery of drugs
|
|
HRP20210587T1
(hr)
|
2010-08-05 |
2021-05-28 |
Forsight Vision4, Inc. |
Injekcijski aparat za dostavu lijeka
|
|
PL2600812T3
(pl)
|
2010-08-05 |
2022-01-24 |
Forsight Vision4, Inc. |
Urządzenie do leczenia oczu
|
|
CN103153316B
(zh)
|
2010-08-05 |
2015-08-19 |
弗赛特影像4股份有限公司 |
组合药物递送方法和设备
|
|
PT2605652T
(pt)
|
2010-08-18 |
2018-01-08 |
Samumed Llc |
Dicetonas e hidroxicetonas como ativadores da via de sinalização de catenina
|
|
US20140031769A1
(en)
|
2010-11-19 |
2014-01-30 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
|
US20140114279A1
(en)
|
2010-11-23 |
2014-04-24 |
Richard Klinghoffer |
Modulation neural pathways
|
|
WO2013003620A2
(en)
|
2011-06-28 |
2013-01-03 |
Forsight Vision4, Inc. |
Diagnostic methods and apparatus
|
|
US9102105B2
(en)
|
2011-09-13 |
2015-08-11 |
Vista Scientific Llc |
Method for forming an ocular drug delivery device
|
|
EP2755483B1
(en)
|
2011-09-14 |
2018-11-28 |
Samumed, LLC |
Indazole-3-carboxamides and their use as wnt/b-catenin signaling pathway inhibitors
|
|
WO2013040247A2
(en)
|
2011-09-16 |
2013-03-21 |
Forsight Vision4, Inc. |
Fluid exchange apparatus and methods
|
|
AU2012318257B2
(en)
|
2011-10-11 |
2015-10-01 |
Baxter Healthcare S.A. |
Hemostatic compositions
|
|
CA2851338C
(en)
|
2011-10-11 |
2019-11-05 |
Baxter International Inc. |
Hemostatic compositions
|
|
CA2853356C
(en)
|
2011-10-27 |
2021-03-23 |
Baxter International Inc. |
Hemostatic compositions
|
|
WO2013063530A2
(en)
|
2011-10-28 |
2013-05-02 |
Presage Biosciences, Inc. |
Methods for drug delivery
|
|
CA2865349C
(en)
|
2012-03-06 |
2021-07-06 |
Ferrosan Medical Devices A/S |
Pressurized container containing haemostatic paste
|
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
|
LT2770994T
(lt)
|
2012-05-04 |
2019-12-10 |
Samumed Llc |
1h-pirazolo[3,4-b]piridinai ir jų terapiniai panaudojimai
|
|
JP6394916B2
(ja)
|
2012-06-12 |
2018-09-26 |
フェロサン メディカル デバイシーズ エイ／エス |
乾燥止血組成物
|
|
CA2897400A1
(en)
|
2013-01-08 |
2014-07-17 |
Samumed, Llc |
3-(benzoimidazol-2-yl)-indazole inhibitors of the wnt signaling pathway and therapeutic uses thereof
|
|
BR112015020391B1
(pt)
|
2013-02-22 |
2022-07-26 |
Samumed, Llc |
Gama-dicetonas como ativadoras da via de sinalização de wnt/beta-catenina
|
|
CA2905496A1
(en)
|
2013-03-14 |
2014-09-25 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
|
AU2014241163B2
(en)
|
2013-03-28 |
2018-09-27 |
Forsight Vision4, Inc. |
Ophthalmic implant for delivering therapeutic substances
|
|
JP6390873B2
(ja)
|
2013-06-21 |
2018-09-19 |
フェッローサン メディカル ディバイス エー／エス |
減圧膨張させた乾燥組成物およびそれを保持するためのシリンジ
|
|
EP3470094B1
(en)
|
2013-12-11 |
2020-07-22 |
Ferrosan Medical Devices A/S |
Dry composition comprising an extrusion enhancer
|
|
KR20160135283A
(ko)
|
2014-03-20 |
2016-11-25 |
사뮤메드, 엘엘씨 |
5-치환된 인다졸-3-카르복스아미드 및 이의 제조 및 용도
|
|
AU2015301054B2
(en)
|
2014-08-08 |
2020-05-14 |
Forsight Vision4, Inc. |
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
|
|
EP3206686B1
(en)
|
2014-08-20 |
2019-10-09 |
Samumed, LLC |
Gamma-diketones for treatment and prevention of aging skin and wrinkles
|
|
WO2016040190A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
|
WO2016040193A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
|
WO2016040188A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040181A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040180A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040185A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof
|
|
WO2016040184A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040182A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-1h-imidazo[4,5-c]pyridine and therapeutic uses thereof
|
|
BR112017007466B1
(pt)
|
2014-10-13 |
2021-03-02 |
Ferrosan Medical Devices A/S |
método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca
|
|
AU2015346450B2
(en)
|
2014-11-10 |
2020-01-30 |
Forsight Vision4, Inc. |
Expandable drug delivery devices and method of use
|
|
BR112017013565B1
(pt)
|
2014-12-24 |
2021-12-28 |
Ferrosan Medical Devices A/S |
Seringa para retenção e mistura de primeira e segunda substâncias
|
|
US10010502B2
(en)
|
2015-05-19 |
2018-07-03 |
Amorphex Therapeutics Llc |
Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation
|
|
CA2986981A1
(en)
|
2015-07-03 |
2017-01-12 |
Ferrosan Medical Devices A/S |
Syringe for mixing two components and for retaining a vacuum in a storage condition
|
|
WO2017024025A1
(en)
|
2015-08-03 |
2017-02-09 |
Sunil Kumar Kc |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
WO2017024004A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
WO2017024003A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
WO2017023996A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
|
WO2017024021A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
|
WO2017023993A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-indol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
WO2017023972A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
US10166218B2
(en)
|
2015-08-03 |
2019-01-01 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
|
WO2017023980A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
|
US10226448B2
(en)
|
2015-08-03 |
2019-03-12 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof
|
|
US10383861B2
(en)
|
2015-08-03 |
2019-08-20 |
Sammumed, LLC |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
|
US10188634B2
(en)
|
2015-08-03 |
2019-01-29 |
Samumed, Llc |
3-(3H-imidazo[4,5-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
WO2017024010A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
|
WO2017023986A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-indol-2-yl)-1h-indazoles and therapeutic uses thereof
|
|
US10206908B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
|
WO2017024015A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
US10392383B2
(en)
|
2015-08-03 |
2019-08-27 |
Samumed, Llc |
3-(1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
CN108472290A
(zh)
|
2015-11-06 |
2018-08-31 |
萨穆梅德有限公司 |
治疗骨关节炎
|
|
MX2018006234A
(es)
|
2015-11-20 |
2018-08-14 |
Forsight Vision4 Inc |
Estructuras porosas para dispositivos de suministro de medicamentos de liberacion prolongada.
|
|
MX2018012021A
(es)
|
2016-04-05 |
2019-01-24 |
Forsight Vision4 Inc |
Dispositivos de administracion de farmacos oculares implantables.
|
|
AR108325A1
(es)
|
2016-04-27 |
2018-08-08 |
Samumed Llc |
Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
|
|
AR108326A1
(es)
|
2016-04-27 |
2018-08-08 |
Samumed Llc |
Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
|
|
CN109476660B
(zh)
|
2016-06-01 |
2023-04-04 |
拜斯丽治疗有限公司 |
N-(5-(3-(7-(3-氟苯基)-3h-咪唑并[4,5-c]吡啶-2-基)-1h-吲唑-5-基)吡啶-3-基)-3-甲基丁酰胺的制备方法
|
|
CN110709082A
(zh)
|
2016-10-21 |
2020-01-17 |
萨穆梅德有限公司 |
吲唑-3-甲酰胺的使用方法及其作为Wnt/β-连环蛋白信号传导途径抑制剂的用途
|
|
US10758523B2
(en)
|
2016-11-07 |
2020-09-01 |
Samumed, Llc |
Single-dose, ready-to-use injectable formulations
|
|
US10604514B2
(en)
|
2017-10-19 |
2020-03-31 |
Samumed, Llc |
6-(5-membered heteroaryl)isoquinolin-3-yl carboxamides and preparation and use thereof
|
|
US10653688B2
(en)
|
2017-10-27 |
2020-05-19 |
Samumed, Llc |
6-(6-membered heteroaryl and aryl)isoquinolin-3-yl carboxamides and preparation and use thereof
|
|
US10413537B2
(en)
|
2017-10-27 |
2019-09-17 |
Samumed, Llc |
6-(5-membered heteroaryl)isoquinolin-3-yl-(5-membered heteroaryl) carboxamides and preparation and use thereof
|
|
WO2019089835A1
(en)
|
2017-10-31 |
2019-05-09 |
Samumed, Llc |
Diazanaphthalen-3-yl carboxamides and preparation and use thereof
|
|
AU2018372806B2
(en)
|
2017-11-21 |
2024-05-30 |
Forsight Vision4, Inc. |
Fluid exchange apparatus for expandable port delivery system and methods of use
|
|
EP3755696B1
(en)
|
2018-02-23 |
2023-04-05 |
BioSplice Therapeutics, Inc. |
5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof
|
|
EP4321182A3
(en)
|
2018-05-09 |
2024-05-29 |
Ferrosan Medical Devices A/S |
Method for preparing a haemostatic composition
|
|
US10759799B2
(en)
|
2018-06-15 |
2020-09-01 |
Samumed, Llc |
Indazole containing macrocycles and therapeutic uses thereof
|
|
WO2020006429A1
(en)
|
2018-06-28 |
2020-01-02 |
Hepatikos Therapeutics, Llc |
Ask1 isoindolin-1-one inhibitors and methods of use thereof
|
|
WO2020150545A1
(en)
|
2019-01-17 |
2020-07-23 |
Samumed, Llc |
Pyrazole derivatives as modulators of the wnt/b-catenin signaling pathway
|
|
BR112022007332A2
(pt)
|
2019-10-24 |
2022-07-05 |
E Labombard Denis |
Dispositivo ocular, métodos, composição, caixa para conter e dispensar um dispositivo ocular e kit
|
|
WO2021168341A1
(en)
|
2020-02-21 |
2021-08-26 |
Samumed, Llc |
Solid forms of 1-(5-(3-(7-(3-fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)-n,n-dimethylmethanamine
|
|
US11980699B2
(en)
|
2021-09-01 |
2024-05-14 |
Shanghai Qisheng Biological Preparation Co., Ltd. |
Cartilage regeneration using injectable, in situ polymerizable collagen compositions containing chondrocytes or stem cells
|
|
JP2024539620A
(ja)
|
2021-10-12 |
2024-10-29 |
バイオスプライス セラピューティクス インコーポレイテッド |
Ｄｙｒｋ１ａ阻害剤としてのピロロ［２，１－ｆ］［１，２，４］トリアジン誘導体
|
|
EP4415817A1
(en)
|
2021-10-12 |
2024-08-21 |
BioSplice Therapeutics, Inc. |
1h-pyrrolo[2,3-b]pyridines as dyrk1a inhibitors
|
|
CN118434792A
(zh)
|
2021-12-28 |
2024-08-02 |
上海其胜生物制剂有限公司 |
透明质酸-胶原共聚物组合物及其医学应用
|
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
|
WO2023250156A1
(en)
|
2022-06-23 |
2023-12-28 |
Biosplice Therapeutics, Inc. |
4-alkoxypyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof
|
|
AU2023371945A1
(en)
|
2022-11-03 |
2025-05-22 |
Biosplice Therapeutics, Inc. |
4-aminopyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof
|
|
WO2024211797A1
(en)
|
2023-04-07 |
2024-10-10 |
Biosplice Therapeutics, Inc. |
Pyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof
|
|
US20250206746A1
(en)
|
2023-12-22 |
2025-06-26 |
Biosplice Therapeutics, Inc. |
4-alkoxypyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof
|
|
WO2025231425A1
(en)
|
2024-05-03 |
2025-11-06 |
Biosplice Therapeutics, Inc. |
4-aminopyrrolo[2,l-f][l,2,4]triazines and preparation and uses thereof
|